Moderna

A research, published in the Journal of the American Medical Association, found those who received the Moderna vaccine were less…

The yet-to-be peer-reviewed study tested the efficacy and safety of vaccines and analysed whether the combination of vaccines from…

"The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to…

The technical group, made up of independent experts, said it would consider a change in vaccination composition and stressed that…

The company in November said its sales could be in the range of $17 billion to $22 billion in 2022

The companies have partnered to discover, develop and commercialise in-vivo engineered Chimeric Antigen Receptor Monocyte (CAR-M)…

The study, sponsored by the vaccine developer, was conducted between 1st January and 7th September last year, before the Omicron…

"Right now, if you got J&J, you get a booster after two months, if you got Pfizer as your primary series you can get a booster…

The company still plans to develop a vaccine specifically to protect against Omicron, which it hopes to advance into clinical…

The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats…